Lamivudine 150 MG Zidovudine 300 MG Oral Tablet Combivir

1 INDICATIONS AND USAGE COMBIVIR, a combination of 2 nucleoside analogues, is indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 (HIV‑1) infection. COMBIVIR, a combination of 2 nucleoside analogue reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV‑1 infection. ( 1 )

ViiV Healthcare Company

FDA Reported Adverse Reactions
`[1] pain` `[2] drug dependence` `[3] drug ineffective` `[4] fatigue` `[5] overdose` `[6] nausea` `[7] headache` `[8] drug hypersensitivity` `[9] diarrhoea` `[10] vomiting`

4 years ago

OVAL WHITE GX FC3

16 HOW SUPPLIED/STORAGE AND HANDLING COMBIVIR tablets, containing 150 mg lamivudine and 300 mg zidovudine, are white, scored, film‑coated, modified‑capsule-shaped tablets, debossed on both tablet faces, such that when broken in half, the full “GXFC3” code is present on both halves of the tablet (“GX” on one face and “FC3” on the opposite face of the tablet). They are available as follows: 60 Tablets/Bottle (NDC 49702-202-18). Store between 2° and 30°C (36° and 86°F).

More pills like OVAL GX FC3

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Lamivudine 150 MG Zidovudine 300 MG Oral Tablet Combivir

FDA Reported Adverse Reactions [1] pain [2] drug dependence [3] drug ineffective [4] fatigue [5] overdose [6] nausea [7] headache [8] drug hypersensitivity [9] diarrhoea [10] vomiting

OVAL WHITE GX FC3

More pills like OVAL GX FC3

FDA Reported Adverse Reactions
`[1] pain` `[2] drug dependence` `[3] drug ineffective` `[4] fatigue` `[5] overdose` `[6] nausea` `[7] headache` `[8] drug hypersensitivity` `[9] diarrhoea` `[10] vomiting`